Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.

Daniel Lindholm; Robert F Storey; Christina Christersson; Sigrun Halvorsen; Erik L Grove; Oscar Braun; Christoph Varenhorst; Stefan K James

doi:10.1016/j.ahj.2015.06.014

Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.

Daniel Lindholm, Robert F Storey, Christina Christersson, Sigrun Halvorsen, Erik L Grove, Oscar Braun, Christoph Varenhorst, Stefan K James

Cardiology

Research output: Contribution to journal › Article › peer-review

Abstract

Ticagrelor treatment has the side effect of increased incidence of dyspnea. Adenosine-induced dyspnea is augmented by ticagrelor and can be alleviated with the adenosine antagonist theophylline. Caffeine is a closely related xanthine derivative.

Original language	English
Pages (from-to)	465-470
Journal	American Heart Journal
Volume	170
Issue number	3
DOIs	https://doi.org/10.1016/j.ahj.2015.06.014
Publication status	Published - 2015

Subject classification (UKÄ)

Cardiology and Cardiovascular Disease

Access to Document

10.1016/j.ahj.2015.06.014

http://www.ncbi.nlm.nih.gov/pubmed/26385029?dopt=Abstract

Cite this

@article{537fd11d091c4417969413326260cd8c,

title = "Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.",

abstract = "Ticagrelor treatment has the side effect of increased incidence of dyspnea. Adenosine-induced dyspnea is augmented by ticagrelor and can be alleviated with the adenosine antagonist theophylline. Caffeine is a closely related xanthine derivative.",

author = "Daniel Lindholm and Storey, {Robert F} and Christina Christersson and Sigrun Halvorsen and Grove, {Erik L} and Oscar Braun and Christoph Varenhorst and James, {Stefan K}",

year = "2015",

doi = "10.1016/j.ahj.2015.06.014",

language = "English",

volume = "170",

pages = "465--470",

journal = "American Heart Journal",

issn = "1097-6744",

publisher = "Mosby-Elsevier",

number = "3",

}

TY - JOUR

T1 - Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.

AU - Lindholm, Daniel

AU - Storey, Robert F

AU - Christersson, Christina

AU - Halvorsen, Sigrun

AU - Grove, Erik L

AU - Braun, Oscar

AU - Varenhorst, Christoph

AU - James, Stefan K

PY - 2015

Y1 - 2015

N2 - Ticagrelor treatment has the side effect of increased incidence of dyspnea. Adenosine-induced dyspnea is augmented by ticagrelor and can be alleviated with the adenosine antagonist theophylline. Caffeine is a closely related xanthine derivative.

AB - Ticagrelor treatment has the side effect of increased incidence of dyspnea. Adenosine-induced dyspnea is augmented by ticagrelor and can be alleviated with the adenosine antagonist theophylline. Caffeine is a closely related xanthine derivative.

U2 - 10.1016/j.ahj.2015.06.014

DO - 10.1016/j.ahj.2015.06.014

M3 - Article

C2 - 26385029

SN - 1097-6744

VL - 170

SP - 465

EP - 470

JO - American Heart Journal

JF - American Heart Journal

IS - 3

ER -

Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this